NEW
YORK, Sept. 26, 2024 /PRNewswire/ -- IFF
(NYSE:IFF) Pharma Solutions is proud to announce its more than
75-year legacy as an excipient manufacturer with new product
launches and technologies for the pharmaceutical and biotech
industries. Celebrating this pivotal milestone, IFF will spotlight
its latest solutions for nitrosamine mitigation at CPHI 2024,
Milan, Oct.
8-10, booth 6B10. The range includes a new portfolio of low
nitrite excipients and ultrapure alginate biopolymers for
next-generation therapeutic development.
"We are unveiling groundbreaking technologies that refine
polymer expertise, tackling critical industry challenges head-on
and empowering our customers to achieve unparalleled success," said
Angela Strzelecki, President, Pharma
Solutions, IFF. "As we mark over 75 years of market leadership as a
market leading excipient manufacturer, we invite visitors to join
us to witness this transformative journey with us."
Low nitrite excipient solutions
Nitrosamine risk mitigation will take center stage at booth
6B10, where IFF will unveil its expanding portfolio of solutions
for nitrosamine control. Avicel® PH Low Nitrite (LN) is
a range of low nitrite microcrystalline cellulose (MCC) grades
demonstrated to reduce the risk of nitrosamine formation as part of
broader mitigation strategies. IFF's expertise in this space also
extends to its well-established METHOCEL™ family of products. The
Company will spotlight how its advanced analytical method leverages
highly sensitive ion chromatography-mass spectrometry (IC/MS) to
detect nitrites at trace levels down to parts per billion (ppb) in
its METHOCEL™ grades. Furthermore, attendees can look forward to an
exclusive preview of IFF's upcoming low nitrite addition.
Supporting breakthroughs in biotech
Demonstrating its contribution to the future of biotechnology,
IFF will present its expanding ultrapure alginate technologies at
CPHI. NOVAMATRIX-3D™, part of the NovaMatrix® product
portfolio, is an animal-free 3D cell culture system engineered for
efficient cell seeding and enzyme-free cell release. It offers a
more physiologically relevant environment than traditional 2D
cultures, supporting various cell lines and opening new
possibilities for drug development, cancer research, tissue
engineering, toxicity testing and stem cell research. IFF will
also showcase PRONOVA® UP CAM, a specialized ultrapure
calcium alginate allowing for controlled and in-situ
gelation across diverse biomedical applications, from cell and drug
encapsulation systems to advanced wound dressings and tissue
engineering.
New horizons with POLYOX™ ES packaging
In addition to its biopolymer solutions, IFF will introduce new
foil bag-in-box packaging for its POLYOX™ water-soluble resins
(WSR). The packaging extends the stability of POLYOX™ WSR by
providing a moisture and oxygen barrier to preserve polymer
viscosity, improving the product's storage life and supporting more
effective supply chain and inventory management practices. The
packaging is also more easily recyclable than fiber drums providing
more than 85 percent reduction in landfill waste associated with
POLYOX™ WSR packaging to support customers' sustainability
initiatives.
Join IFF's experts to learn how the Company's expanding
capabilities continue to optimize drug product formulation and
drive innovation forward, visit booth 6B10 or schedule an
appointment here.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage,
health, biosciences and scent, science and creativity meet to
create essential solutions for a better world – from global icons
to unexpected innovations and experiences. With the beauty of art
and the precision of science, we are an international collective of
thinkers who partners with customers to bring scents, tastes,
experiences, ingredients and solutions for products the world
craves. Together, we will do more good for people and planet. Learn
more at iff.com, X
(Twitter) , Facebook, Instagram,
and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with
TM, SM or ® are owned by IFF or affiliates of
IFF unless otherwise noted. All Rights Reserved.
SOURCE IFF